Will AbbVie’s $10.9 Billion Acquisition Shape Its Dividend?
AbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
Explore wealth-building tips specifically designed for millennials. Take charge of your financial future with practical advice and strategies.
10,859 articlesAbbVie just agreed to buy Apogee Therapeutics for $10.9 billion in cash. This move could reshape the company’s cash f...
As AI compute demand climbs, investors wonder if nebius group stock still holds appeal after Meta's AI cloud move. Th...
Jamie Dimon drops a bold note on AI’s real impact at JPMorgan: it’s already trimming headcount in some units, but pro...
A real-world financial wake-up call shows how a missing tarantula collection can expose gaps in protection, insurance...
SERHANT. has named Nick Janovsky as Tampa Bay luxury sales director, adding a veteran broker with a storied track rec...
El Paso’s airspace returns to normal as drone disruptions end, paving the way for resumed flights and new budgeting d...
President Trump has nominated Kevin Warsh to chair the Federal Reserve, a move that could reshape U.S. monetary polic...
Shares FISERV rising today can reflect more than a quick swing. This article breaks down the catalysts, the business ...
A wave of fresh research notes on Thursday targets a mix of tech and consumer names, including Analog Devices, Chewy,...
Sam Altman cautions that some companies are blaming AI for layoffs that were planned for other reasons, a trend with ...
Prices are cooling and mortgage rates linger above historical lows. This piece unpacks whether we’re at a turning poi...
As GLP-1 obesity therapies surge, one company is capturing the lion’s share of prescriptions and profits. This in-dep...